Reverse Genetics Methods: What's Known, What's New, What's Next On The Agenda

The last decade has seen extraordinary advances in identifying single genes that are responsible for a variety of human diseases. Most recantly researchers have pinpointed the genes that cause retinoblastoma, chronic granulomatous disease, muscular dystrophy, and cystic fibrosis, the last as recently as September. Ingenious experimental design and new technologies are helping to pave the way for rapid identification of other disease-causing genes. And from there, the development of improved d

Written byLisa Holland
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The last decade has seen extraordinary advances in identifying single genes that are responsible for a variety of human diseases. Most recantly researchers have pinpointed the genes that cause retinoblastoma, chronic granulomatous disease, muscular dystrophy, and cystic fibrosis, the last as recently as September. Ingenious experimental design and new technologies are helping to pave the way for rapid identification of other disease-causing genes. And from there, the development of improved diagnostic procedures and therapeutic treatments is sure to follow, say experts.

For most genetic diseases, the normal function of the involved gene is not known. Localizing a disease-causing gene without knowing anything about the disease’s molecular or biochemical nature is , called “reverse genetics.” The process of identifying such genes is laborious, since there are between 50,000 and 100,000 genes distributed within 3 billion base pairs of DNA. But recently developed techniques are greatly expediting such searches for the proverbial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies